Jerry Avorn

Jerry Avorn

Harvard Medical School
Verified email at partners.org
Cited by 122982
pharmacoepidemiology side effects drug policy academic detailing prescription drugs
G. Caleb Alexander

G. Caleb Alexander

Johns Hopkins Center for Drug Safety and Effectiveness
Verified email at jhsph.edu
Cited by 28923
Drug utilization pharmacoepidemiology pharmaceutical policy prescription drugs drug safety
Walid Gellad

Walid Gellad

University of Pittsburgh, VA, RAND
Verified email at rand.org
Cited by 9795
Health Policy Prescription Drugs Medication Adherence
Huseyin Naci

Huseyin Naci

London School of Economics
Verified email at lse.ac.uk
Cited by 8087
Health Policy Pharmaceutical Policy Pharmaceutical Regulation Prescription Drugs
Olivier J. Wouters

Olivier J. Wouters

Assistant Professor, London School of Economics
Verified email at lse.ac.uk
Cited by 4105
Access to Medicines Pharmaceutical Policy Prescription Drugs
Benjamin N. Rome

Benjamin N. Rome

Brigham and Women's Hospital
Verified email at bwh.harvard.edu
Cited by 3840
Health Policy Prescription drugs Health Care Cost Pharmacoepidemiology
Yuting Zhang

Yuting Zhang

Professor, University of Melbourne
Verified email at unimelb.edu.au
Cited by 3688
health policy health economics prescription drugs pharmaceutical policy
M. Christopher Roebuck

M. Christopher Roebuck

Principal, RxEconomics LLC
Verified email at rxeconomics.com
Cited by 3590
health economics pharmacoeconomics outcomes research prescription drugs adherence
Ana Ludke

Ana Ludke

Health Canada
Verified email at ludke.ca
Cited by 1136
Cardio-renal prescription drugs
James Baumgardner

James Baumgardner

Scientific Advisor and Senior Research Economist, PRECISIONheor
Verified email at precisionvh.com
Cited by 681
health care policy Medicare Prescription Drugs Cost-effectiveness federal budget
1 - 10